2005 Annual Session

2008 Topics

	Additional Topics
	Associates, Residents and Fellows in Training
	Cardiology
	Career and Professionalism
	Clinical Pearls
	Computer in Practice
	Clinical Pharmacology
	Ethics and Health Policy
	Endocrinology
	Gastroenterology and Hepatology
	Health Issues Related to Age and Gender
	Hematology
	Hospital Medicine
	Infectious Diseases
	Medical Practice Management
	Multiple Small Feedings of the Mind
	Nephrology and Hypertension
	Neurology
	Oncology
	Ophthalmology and Otolaryngology
	Perioperative Medicine
	Pre-Session Courses
	Psychiatry
	Pulmonary Diseases and Critical Care
	Rheumatology and Allergy & Immunology
	Updates

New Directions in Treatment of Diabetic Kidney Disease: ACEs, ARBs or Both? And What About Aldosterone?

Session #: 855-206
Presenter(s): Robert D. Toto
Session Length: 1:30 hr
Event: 2005 ACP Annual Session
Date: April 14-16, 2005

Purchase Media - Session #: 855-206
Description	Price	Qty.	Cart
MP3	$17.00		buy now
CD	$17.00		buy now
iPod Audio	$17.00		buy now

Clinical questions to be addressed:
What is the natural history of renal disease in patients with diabetes?
What is the proper therapy of renal disease in patients with diabetes mellitus?
Is combination therapy with angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers safe and effective for patients with diabetic renal disease?
Is there a role of spironolactone in combination therapy with other drugs in patients with diabetic nephropathy?

About